User profiles for PIERO LUIGI ALO

piero alo

professore di anatomia patologica università di roma la sapienza
Verified email at uniroma1.it
Cited by 2990

Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma

…, RP Donnorso, G Lombardi, PL Alo - Anticancer …, 2004 - ar.iiarjournals.org
Background: We explored the expression of Fatty Acid Synthase (FAS) in lung carcinomas
and its association with clinico-pathological features and prognosis. FAS is a recently …

Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma

…, V Piccini, BC de Joannon, U Di Tondo, PL Alo - Gynecologic …, 2004 - Elsevier
Purpose. To explore the expression of fatty acid synthase (FAS) and human erythrocyte
glucose transporter 1 (GLUT1) in endometrial carcinomas and to detect associations with …

Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas …

P Visca, PL Alò, FD Nonno, C Botti, G Trombetta… - Clinical Cancer …, 1999 - AACR
Piero Luigi Alò; Piero Luigi Alò … Paolo Visca, Piero Luigi Alò, Franca Del Nonno, Claudio
Botti, Giorgio Trombetta, Ferdinando Marandino, Stefania Filippi, Ugo Di Tondo, Raffaele …

Immunohistochemical study of fatty acid synthase in ovarian neoplasms.

PL Alo, P Visca, ML Framarino, C Botti… - Oncology …, 2000 - spandidos-publications.com
In order to evaluate the prognostic significance of fatty acid synthase (FAS), the key enzyme
in fatty acid biosynthesis, in ovarian benign and malignant tumors 98 patients with ovarian …

Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay …

…, R Scialpi, M Benevolo, T Lucante, P Luigi Alò… - …, 2022 - Wiley Online Library
Aims The introduction of immunotherapy for patients with head and neck squamous cell
carcinoma (HNSCC) raises the need for harmonisation between different types of antibody and …

Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma

…, R Murari, C Botti, E Pica, G Zotti, PL Alo - Anticancer …, 2010 - ar.iiarjournals.org
HER2 gene amplification was explored using the silver stain hybridization in situ (SISH)
technique in colon, prostate, lung, ovarian and breast carcinomas. Clinical pathological features …

Role and prognostic significance of CD44s expression in colorectal cancer.

…, RP Donnorso, G Trombetta, S Filippi, PL Alo - Anticancer …, 2002 - europepmc.org
Materials and methods CD44s immunohistochemical expression was evaluated in 100
patients with colon adenoma and 100 patients with colon adenocarcinoma and adjacent non-…

Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma

…, P Visca, L Pizzuti, G Santeusanio, PL Alo - Anticancer …, 2006 - ar.iiarjournals.org
Background: The aim of this study was to detect immunohistochemical markers in breast
carcinoma by means of tissue microarray analysis (TMA) and to associate their expressions …

Overexpression of fatty acid synthase in ulcerative colitis

A Consolazio, PL Alò, M Rivera… - American journal of …, 2006 - academic.oup.com
Fatty acid synthase (FAS) is an enzyme that catalyzes the synthesis of long-chain fatty acids.
The enzyme expression is minimal in adult tissues and very high in many cancers. …

Laparoscopic diagnosis and treatment of a well-differentiated papillary mesothelioma of the peritoneum

MG Porpora, V Brancato, C D'Elia, M Natili… - The Journal of the …, 2002 - Elsevier
Well-differentiated papillary mesothelioma is a rare neoplasm of peritoneum, found mainly
in women of reproductive age, and usually misdiagnosed as an ovarian mass. A 46-year-old …